Search by Drug Name or NDC
NDC 50991-0736-90 Deconex IR 385; 10 mg/1; mg/1 Details
Deconex IR 385; 10 mg/1; mg/1
Deconex IR is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Poly Pharmaceuticals, Inc.. The primary component is GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 50991-0736-90Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Phenylephrine is used to relieve nasal discomfort caused by colds, allergies, and hay fever. It is also used to relieve sinus congestion and pressure. Phenylephrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Phenylephrine is in a class of medications called nasal decongestants. It works by reducing swelling of the blood vessels in the nasal passages.
Related Packages: 50991-0736-90Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Phenylephrine
Product Information
| NDC | 50991-0736 |
|---|---|
| Product ID | 50991-736_efbbcabc-f615-8aba-e053-2995a90a249a |
| Associated GPIs | 43996202100317 |
| GCN Sequence Number | 076492 |
| GCN Sequence Number Description | guaifenesin/phenylephrine HCl TABLET 385MG-10MG ORAL |
| HIC3 | B4W |
| HIC3 Description | DECONGESTANT-EXPECTORANT COMBINATIONS |
| GCN | 42022 |
| HICL Sequence Number | 000250 |
| HICL Sequence Number Description | GUAIFENESIN/PHENYLEPHRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Deconex IR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Guaifenesin and Phenylephrine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 385; 10 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | Poly Pharmaceuticals, Inc. |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50991-0736-90 (50991073690)
| NDC Package Code | 50991-736-90 |
|---|---|
| Billing NDC | 50991073690 |
| Package | 1 BOTTLE in 1 CARTON (50991-736-90) / 90 TABLET in 1 BOTTLE |
| Marketing Start Date | 2016-08-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.6246 |
| Pricing Unit | EA |
| Effective Date | 2023-11-22 |
| NDC Description | DECONEX IR 385-10 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |